Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
Collegium Pharmaceutical (Nasdaq: COLL) announced it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. The company will host a live conference call and webcast at 8:00 a.m. ET following the release.
Conference call dial-in numbers are (877) 407-8037 (U.S.) and (201) 689-8037 (International) referencing the “Collegium Pharmaceutical Q3 2025 Earnings Call.” An audio webcast and a replay will be available from the Investors section of the company website at www.collegiumpharma.com, with the replay posted about two hours after the event.
Collegium Pharmaceutical (Nasdaq: COLL) ha annunciato che divulgherà i risultati finanziari del terzo trimestre 2025 prima dell'apertura del mercato giovedì 6 novembre 2025. L'azienda terrà una conference call in diretta e un webcast subito dopo il rilascio alle 8:00 a.m. ET.
I numeri per la conference call sono (877) 407-8037 (USA) e (201) 689-8037 (Internazionale) con riferimento a “Collegium Pharmaceutical Q3 2025 Earnings Call.” Un webcast audio e una replica saranno disponibili nella sezione Investitori del sito web aziendale all'indirizzo www.collegiumpharma.com, con la replica pubblicata circa due ore dopo l'evento.
Collegium Pharmaceutical (Nasdaq: COLL) anunció que reportará los resultados financieros del tercer trimestre 2025 antes de la apertura del mercado el jueves 6 de noviembre de 2025. La empresa organizará una conferencia telefónica en vivo y un webcast a las 8:00 a. m. ET tras la publicación.
Los números para la conferencia son (877) 407-8037 (EE. UU.) y (201) 689-8037 (Internacional), haciendo referencia a la “Collegium Pharmaceutical Q3 2025 Earnings Call.” Un webcast de audio y una réplica estarán disponibles en la sección de Inversores del sitio web de la empresa en www.collegiumpharma.com, con la réplica publicada aproximadamente dos horas después del evento.
Collegium Pharmaceutical (Nasdaq: COLL) 은 2025년 3분기 재무 실적을 2025년 11월 6일 목요일 시장 개장 전에 발표한다고 발표했습니다. 회사는 발표 직후 동부 표준시 기준 오전 8:00에 라이브 컨퍼런스 콜과 웹캐스트를 주최합니다.
컨퍼런스 콜 다이얼링 번호는 (877) 407-8037 (미국) 및 (201) 689-8037 (국제) 로 “Collegium Pharmaceutical Q3 2025 Earnings Call”를 참조합니다. 오디오 웹캐스트와 재생은 기업 웹사이트의 투자자 섹션에서 www.collegiumpharma.com에서 이용 가능하며, 이벤트 후 약 두 시간 후에 재생이 게시됩니다.
Collegium Pharmaceutical (Nasdaq: COLL) a annoncé qu'il publiera les résultats financiers du troisième trimestre 2025 avant l'ouverture du marché le jeudi 6 novembre 2025. L'entreprise organisera une conférence téléphonique en direct et un webcast à 8 h 00, heure de l'Est après la publication.
Les numéros d'appel pour la conférence sont (877) 407-8037 (États-Unis) et (201) 689-8037 (International), en référence à « Collegium Pharmaceutical Q3 2025 Earnings Call ». Un webcast audio et une rediffusion seront disponibles dans la section Investisseurs du site Web de l'entreprise à l'adresse www.collegiumpharma.com, la rediffusion étant publiée environ deux heures après l'événement.
Collegium Pharmaceutical (Nasdaq: COLL) hat bekannt gegeben, dass es die Finanzergebnisse des dritten Quartals 2025 vor Handelsbeginn am Donnerstag, der 6. November 2025 berichten wird. Das Unternehmen wird nach der Veröffentlichung einen Live-Konferenzanruf und einen Webcast veranstalten um 8:00 Uhr ET.
Dial-in-Nummern für die Konferenz sind (877) 407-8037 (USA) und (201) 689-8037 (International), mit Verweis auf „Collegium Pharmaceutical Q3 2025 Earnings Call.“ Ein Audio-Webcast und eine Wiederholung stehen im Bereich Investoren der Unternehmenswebsite unter www.collegiumpharma.com zur Verfügung, die Wiederholung wird etwa zwei Stunden nach der Veranstaltung veröffentlicht.
شركة Collegium Pharmaceutical (ناسداك: COLL) أعلنت أنها ستعلن النتائج المالية للربع الثالث من عام 2025 قبل فتح السوق يوم الخميس 6 نوفمبر 2025. ستستضيف الشركة مكالمة مؤتمر مباشرة وبثاً على الويب في 8:00 صباحاً بتوقيت شرق الولايات المتحدة بعد الإصدار.
أرقام الاتصال بمكالمة المؤتمر هي (877) 407-8037 (الولايات المتحدة) و(201) 689-8037 (دولية) مع الإشارة إلى “Collegium Pharmaceutical Q3 2025 Earnings Call.” سيكون هناك بث صوتي ونسخة قابلة لإعادة التشغيل من قسم المستثمرين في موقع الشركة على الويب بعنوان www.collegiumpharma.com، وستُطرح النسخة القابلة لإعادة التشغيل بعد حوالي ساعتين من الحدث.
Collegium Pharmaceutical (Nasdaq: COLL) 宣布将于市场开盘前披露2025 年第三季度财务结果，时间为2025 年 11 月 6 日，星期四。公司将在披露后举行现场电话会议和网络广播，时间为美东时间上午 8:00。
电话会议的拨入号码为(877) 407-8037（美国）和(201) 689-8037（国际），参见“Collegium Pharmaceutical Q3 2025 Earnings Call”。音频 webcast 及回放将可在公司网站的投资者栏目中获取，网站地址为www.collegiumpharma.com，回放大约在活动结束后两小时发布。
- None.
- None.
STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q3 2025 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
FAQ
When will Collegium (COLL) report Q3 2025 financial results?
What time is the Collegium (COLL) Q3 2025 earnings call and webcast?
How can investors join the Collegium (COLL) Q3 2025 conference call?
Where can I access the Collegium (COLL) earnings webcast and replay?
Will the Collegium (COLL) earnings webcast be available for replay and when?
